60 Results for "

MT2

" in MedChemExpress (MCE) Product Catalog:
Products (60)

60 Results for "MT2" in MCE Product Catalog:

  • Isoforms Recommended:
18
18 Publications Verification
Cat. No.: HY-101254
CAS No.: 117946-91-5
Purity:  100.0%
Synonyms: N-0774
Target:  

Melatonin Receptor

Research Areas:  

Neurological Disease

Luzindole (N-0774) is a selective melatonin receptor antagonist. Luzindole preferentially targets MT2 (Mel1b) over MT1 (Mel1a) with Ki values of 10.2 and 158 nM for human MT2 and MT1, respectively. Luzindole suppresses experimental autoimmune encephalomyelitis (EAE), and exerts antidepressant-like activity [2] .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-100609
CAS No.: 134865-74-0
Purity:  99.90%
Target:  

Melatonin Receptor

Research Areas:  

Neurological Disease

4-P-PDOT is a potent, selective and affinity Melatonin receptor (MT2) antagonist. 4-P-PDOT is >300-fold more selective for MT2 than MT1. 4-P-PDOT significantly counteracts Melatonin-mediated antioxidant effects (GSH/GSSG ratio, phospho-ERK, Nrf2 nuclear translocation, Nrf2 DNA-binding activity) [2] .
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-A0014
CAS No.: 196597-26-9
Synonyms: TAK-375
Ramelteon is a potent, highly selective, and orally active agonist of MT1/MT2 with Ki values of 14 and 112 pM, respectively. Ramelteon has the potential for the research of insomnia. Ramelteon consistently reduces sleep onset after long-term treatment, with no next-morning residual effects or rebound insomnia or withdrawal symptoms upon discontinuation [2].
loading...
    loading...
12
12 Cited Publications
Cat. No.: HY-122136
CAS No.: 296280-56-3
Purity:  99.63%
Target:  

Melatonin Receptor

Research Areas:  

Neurological Disease

S26131 (compound 5) is a potent and selective MT1 melatoninergic ligand, and the Ki values are 0.5 and 112 nM for MT1 and MT2, respectively. S26131 behaves as an MT1 and MT2 antagonist .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-17038
CAS No.: 138112-76-2
Synonyms: S-20098
Agomelatine (S-20098) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively . Agomelatine is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively [2].
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-17038A
CAS No.: 1176316-99-6
Synonyms: S-20098 hydrochloride
Agomelatine hydrochloride (S-20098 hydrochloride) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively . Agomelatine hydrochloride is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively [2].
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-17038B
CAS No.: 824393-18-2
Synonyms: S-20098 L(+)-Tartaric acid
Agomelatine L(+)-Tartaric acid (S-20098 L(+)-Tartaric acid) is a specific agonist of MT1 and MT2 receptors with Kis of 0.1, 0.06, 0.12, and 0.27 nM for CHO-hMT1, HEK-hMT1, CHO-hMT2, and HEK-hMT2, respectively . Agomelatine L(+)-Tartaric acid is a selective 5-HT2C receptor antagonist with pKis of 6.4 and 6.2 at native (porcine) and cloned, human 5-HT2C receptors, respectively [2].
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-101176
CAS No.: 93515-00-5
Purity:  ≥99.0%
Target:  

Melatonin Receptor

Research Areas:  

Cancer

2-Iodomelatonin is a potent agonist of melatonin receptor 1 (MT1) with a Ki value of 28 pM, it is more 5-fold selective for MT1 over MT2 . 2-iodomelatonin can be used to identify, characterize and localize melatonin binding sites in the brain and peripheral tissues .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N0842
CAS No.: 174022-42-5
Synonyms: PA-457; MPC-4326; YK FH312
Bevirimat (PA-457, MPC-4326, YK FH312) is an inhibitor of HIV-1 viral particle maturation.Bevirimat specifically inhibits the final rate-limiting step in Gag processing, preventing the release of the mature capsid protein (CA) from its precursor (CA-SP1), resulting in the production of immature non-infectious viral particles. Bevirimat can be used in HIV-1 infection studies [2] .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-105285
CAS No.: 946846-83-9
Purity:  99.54%
Synonyms: Neu-P11
Piromelatine (Neu-P11) is a melatonin MT1/MT2 receptor agonist, serotonin 5-HT1A/5-HT1D agonist, and serotonin 5-HT2B antagonist. Piromelatine (Neu-P11) possesses sleep promoting, analgesic, anti-neurodegenerative, anxiolytic and antidepressant potentials. Piromelatine (Neu-P11) also possesses pain-related P2X3, TRPV1, and Nav1.7 channel-inhibition capacities [2] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-14803
CAS No.: 609799-22-6
Purity:  99.68%
Synonyms: BMS-214778; VEC-162
Target:  

Melatonin Receptor

Research Areas:  

Neurological Disease Endocrinology

Tasimelteon (BMS-214778) is an orally active and selective dual melatonin receptor agonist (DMRA). Tasimelteon has 2.1-4.4 times greater affinity for the MT2 receptor than for the MT1 receptor. Tasimelteon is a circadian regulator and has the potential for Non-24-Hour Sleep-Wake Disorder (Non-24) [2].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101358
CAS No.: 134865-70-6
Purity:  99.54%
Synonyms: AH-002
Target:  

Melatonin Receptor

Research Areas:  

Neurological Disease

8-M-PDOT (AH-002) is a selective melatonin MT2 receptor agonist. 8-M-PDOT is 5.2-fold selective for MT2 over MT1 receptors. 8-M-PDOT binds human recombinant MT2 and MT2 receptors with pKi values of 8.23 and 8.95 respectively. 8-M-PDOT has anxiolytic-like activity [2].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-133113
CAS No.: 152302-45-9
Purity:  99.89%
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

7-Desmethyl-agomelatine is a metabolite of Agomelatine. Agomelatineis a potent agonist at melatonin receptors (MT1 and MT2), and also is an antagonist of 5-HT2C [2].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-114962
CAS No.: 180304-07-8
Purity:  99.88%
Target:  

Melatonin Receptor

Research Areas:  

Neurological Disease

S-22153 is a potent melatonin receptor antagonist with EC50 values of 19 nM, 4.6 nM for hMT1 and hMT2 melatonin receptor, respectively. S-22153 has Ki values of 8.6 nM (CHO cells) and 16.3 nM (HEK cells) for hMT1, and 6.0 nM (CHO cells) and 8.2 nM (HEK cells) for hMT2. S-22153 is a specific ligand of MT1 and MT2 melatonin receptors subtypes [2].
loading...
    loading...
Cat. No.: HY-103005S
CAS No.: 1246812-22-5
Purity:  ≥99.0%
Ramelteon metabolite M-II-d3 is the deuterium labeled Ramelteon metabolite M-II. Ramelteon metabolite M-II is the major metabolite of Ramelteon, with IC50s of 208 pM, 1470 pM for human melatonin receptors (MT1 or MT2). Ramelteon is a selective melatonin agonist [2].
loading...
    loading...
Cat. No.: HY-103005
CAS No.: 896736-21-3
Purity:  98.24%
Ramelteon metabolite M-II is the major metabolite of Ramelteon, with IC50s of 208 pM, 1470 pM for human melatonin receptors (MT1 or MT2). Ramelteon is a selective melatonin agonist.
loading...
    loading...
Cat. No.: HY-A0014S1
CAS No.: 1432057-38-9
Synonyms: TAK-375-d3
Ramelteon-d3 (TAK-375-d3) is a deuterium-labelled Ramelteon (HY-A0014). Ramelteon is a potent, highly selective, and orally active agonist of MT1/MT2 with Ki values of 14 and 112 pM, respectively. Ramelteon has the potential for the research of insomnia. Ramelteon consistently reduces sleep onset after long-term treatment, with no next-morning residual effects or rebound insomnia or withdrawal symptoms upon discontinuation.
loading...
    loading...
Cat. No.: HY-138626
CAS No.: 2225836-30-4
Purity:  98.58%
Target:  

Melatonin Receptor

Research Areas:  

Metabolic Disease

ACH-000143 is a potent and orally active melatonin receptor agonist, with EC50 values of 0.06 nM and 0.32 nM for MT1 and MT2, respectively .
loading...
    loading...
Cat. No.: HY-107628
CAS No.: 220339-00-4
Target:  

Melatonin Receptor

Research Areas:  

Neurological Disease

N-Pentanoyl 2-benzyltryptamine is a potent and selective antagonist of MT2 melatonin receptor, with a pKi of 8.03 for human MT2. N-Pentanoyl 2-benzyltryptamine shows 89- and 229-fold selectivity for human MT2 over human mt1 and Xenopus mel1c receptor subtypes. N-Pentanoyl 2-benzyltryptamine can inhibit melatonin-induced enhancement of electrically-evoked responses [2].
loading...
    loading...
Cat. No.: HY-RS08743
Research Areas:  

Others

MT2A Human Pre-designed siRNA Set A contains three designed siRNAs for MT2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...